A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)

NCT05261126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Familial Hypercholesterolemia

Interventions

DRUG: Enclitide Chloride
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC